1
55ESPE Poster presented at: Endocrine and Metabolic Evaluation of Children with Neurodevelopmental Disability Giorgiana-Flavia Brad a,b , Tamara Marcovici a,b , Oana Belei a,b , Teofana Bizerea a,b , Niculina Mang a,b , Raluca Tamasanu a,b , Otilia Marginean a,b a Victor Babes University of Medicine and Pharmacy, Timisoara, Romania b Louis Turcanu Children Emergency Hospital, Timisoara, Romania Introduction: Neurodevelopmental disability (NDD) is a common problem in children health, occurring in 5–10% of the pediatric population. Aim: To evaluate the endocrine and metabolic complications described in patients with NDD. Material and method: Children with NDD, aged below 9 years old, admitted to 1 st Pediatric Clinic of Children Emergency Hospital, Timisoara, Romania, between January 2014-March 2016 were included in this study. Their evaluation was complex and included a detailed medical history, clinical and anthropometric evaluation, Tanner stages, multiple serum analyses and sophisticated imagistic investigations. Results: A total of 15 children (53.33% boys) diagnosed with NDD, with a mean age of 6.5±1.9 years were eligible for this study. The main complaints were developmental delay (93.33%) and developmental regression (6.67%). Cerebral palsy was the most common clinical syndrome (60%), being caused mostly by perinatal hypoxic-ischemic encephalopathy (55.56%) and prematurity with intraventricular haemorrhage (33.33%). Metabolic disorders were diagnosed in 13.33% of them (1 with phenylketonuria and 1 with renal tubular acidosis), while 1 had clinical manifestations of neurodegenerative disorders (X-linked adreno-leukodystrophy).Severe malnutrition was encountered in 66.67% of them and short stature in 60%. The main metabolic factors responsible for atraumatic fractures are presented in Figure no.1. In almost one third of cases, these were encountered especially in patients with seizures treated with an association of two (50%) or more anticonvulsivants (33.33%) and difficulty feeding problems (66.67%). In Figure no. 2 are presented the endocrine disorders associated in our patients. Conclusion: Evaluation endocrine and metabolic complications in patients with NDD is essential and helps for appropriate rehabilitation, family counseling and management of these associated medical conditions. [email protected] 0% 10% 20% 30% 40% 50% 60% Hypocalcemia with vitamin D deficiency Hypophosphatemic rickets Osteopenia Osteogenesis imperfecta 60% 6,67% 20% 6,67% Figure no.1-Metabolic factors responsible for fractures 0% 5% 10% 15% 20% 25% 30% 35% 40% 45% 50% Subclinical hypothyroidism Adrenal insufficiency Premature adrenarche Premature telarche Central precious puberty 26,67% 6,67% 46,67% 33,33% 13,34% Figure no. 2-Endocrine disorders associated P2-P718 718--P2 giorgiana brad DOI: 10.3252/pso.eu.55ESPE.2016 Endocrinology and Multisystemic Diseases

Endocrine and Metabolic Evaluation of Children with ...abstracts.eurospe.org/hrp/0086/eposters/hrp0086p2-p718_eposter.pdf · SPE Poster presented at: Endocrine and Metabolic Evaluation

  • Upload
    others

  • View
    0

  • Download
    0

Embed Size (px)

Citation preview

Page 1: Endocrine and Metabolic Evaluation of Children with ...abstracts.eurospe.org/hrp/0086/eposters/hrp0086p2-p718_eposter.pdf · SPE Poster presented at: Endocrine and Metabolic Evaluation

55

ESP

E

Poster

presented at:

Endocrine and Metabolic Evaluation of Children with Neurodevelopmental Disability

Giorgiana-Flavia Brad a,b, Tamara Marcovici a,b, Oana Belei a,b, Teofana Bizerea a,b, Niculina Mang a,b, Raluca Tamasanu a,b, Otilia Marginean a,b

a Victor Babes University of Medicine and Pharmacy, Timisoara, Romaniab Louis Turcanu Children Emergency Hospital, Timisoara, Romania

Introduction: Neurodevelopmental disability (NDD) is a common problem in children health, occurring in5–10% of the pediatric population.

Aim: To evaluate the endocrine and metabolic complications described in patients with NDD.

Material and method: Children with NDD, aged below 9 years old, admitted to 1st Pediatric Clinic ofChildren Emergency Hospital, Timisoara, Romania, between January 2014-March 2016 were included inthis study. Their evaluation was complex and included a detailed medical history, clinical andanthropometric evaluation, Tanner stages, multiple serum analyses and sophisticated imagisticinvestigations.

Results: A total of 15 children (53.33% boys) diagnosed with NDD, with a mean age of 6.5±1.9 years

were eligible for this study. The main complaints were developmental delay (93.33%) and developmentalregression (6.67%). Cerebral palsy was the most common clinical syndrome (60%), being caused mostlyby perinatal hypoxic-ischemic encephalopathy (55.56%) and prematurity with intraventricularhaemorrhage (33.33%). Metabolic disorders were diagnosed in 13.33% of them (1 with phenylketonuriaand 1 with renal tubular acidosis), while 1 had clinical manifestations of neurodegenerative disorders(X-linked adreno-leukodystrophy).Severe malnutrition was encountered in 66.67% of them and shortstature in 60%. The main metabolic factors responsible for atraumatic fractures are presented in Figureno.1. In almost one third of cases, these were encountered especially in patients with seizures treatedwith an association of two (50%) or more anticonvulsivants (33.33%) and difficulty feeding problems(66.67%). In Figure no. 2 are presented the endocrine disorders associated in our patients.

Conclusion: Evaluation endocrine and metabolic complications in patients with NDD is essential and helpsfor appropriate rehabilitation, family counseling and management of these associated medical conditions.

[email protected]

0%

10%

20%

30%

40%

50%

60%

Hypocalcemia with vitamin D deficiency

Hypophosphatemicrickets

Osteopenia Osteogenesisimperfecta

60%

6,67%

20%

6,67%

Figure no.1-Metabolic factors responsible for fractures

0%

5%

10%

15%

20%

25%

30%

35%

40%

45%

50%

Subclinicalhypothyroidism

Adrenal insufficiency

Prematureadrenarche

Prematuretelarche

Central preciouspuberty

26,67%

6,67%

46,67%

33,33%

13,34%

Figure no. 2-Endocrine disorders associated

P2-P718

718--P2giorgiana brad DOI: 10.3252/pso.eu.55ESPE.2016

Endocrinology and Multisystemic Diseases